Engineered enzyme reportedly clears sugar damage from donor aorta tissue
A publication cites a Nature Communications study in which an engineered enzyme reportedly removed more than 70% of a sugar-related damage product from donor aorta tissue. It is early tissue research.
Source: Engineered enzyme reportedly clears sugar damage from donor aorta tissue (x.com). Summary written with AI from the source and reviewed by rules; read the original.
What the research shows
The publication cites a study in the journal Nature Communications. In it, an engineered enzyme was applied to the aorta of a 75-year-old donor and reportedly removed more than 70% of CML, a product of sugar-related damage. The result is reported by the publication and appears in tissue, not in living people.
CML is linked to stiffer arteries and inflammation. Even so, this is early research on tissue, not an available treatment. Results in tissue do not show whether something similar would work in the human body, or whether it would be safe or useful.
What it means
The finding suggests an enzyme can lower a marker of sugar-related damage in aorta tissue in an early experiment. It is not yet known whether this would translate into benefit, safety or effects in people.
How to read it with care
A laboratory finding does not replace a medical consultation. Anyone considering a change in diet, supplements or treatment should talk to a doctor or another qualified health professional.